Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 19035461)

1.

Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model.

Dujic J, Kippenberger S, Ramirez-Bosca A, Diaz-Alperi J, Bereiter-Hahn J, Kaufmann R, Bernd A, Hofmann M.

Int J Cancer. 2009 Mar 15;124(6):1422-8. doi: 10.1002/ijc.23997.

PMID:
19035461
2.

Low concentrations of curcumin induce growth arrest and apoptosis in skin keratinocytes only in combination with UVA or visible light.

Dujic J, Kippenberger S, Hoffmann S, Ramirez-Bosca A, Miquel J, Diaz-Alperi J, Bereiter-Hahn J, Kaufmann R, Bernd A.

J Invest Dermatol. 2007 Aug;127(8):1992-2000. Epub 2007 Apr 5.

3.
4.

Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.

Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB.

Clin Cancer Res. 2008 Oct 1;14(19):6228-36. doi: 10.1158/1078-0432.CCR-07-5177.

5.

Curcumin induces apoptosis and inhibits growth of human Burkitt's lymphoma in xenograft mouse model.

Li ZX, Ouyang KQ, Jiang X, Wang D, Hu Y.

Mol Cells. 2009 Mar 31;27(3):283-9. doi: 10.1007/s10059-009-0036-9. Epub 2009 Mar 19.

6.

Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.

Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G, Xu C, Gopalakrishnan A, Reddy B, Zheng X, Conney AH, Kong AN.

Cancer Res. 2006 Jan 15;66(2):613-21.

7.

Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.

Kamat AM, Tharakan ST, Sung B, Aggarwal BB.

Cancer Res. 2009 Dec 1;69(23):8958-66. doi: 10.1158/0008-5472.CAN-09-2045. Epub 2009 Nov 10.

8.

In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells.

Odot J, Albert P, Carlier A, Tarpin M, Devy J, Madoulet C.

Int J Cancer. 2004 Sep 1;111(3):381-7.

PMID:
15221965
9.
10.

Curcumin: a potential radio-enhancer in head and neck cancer.

Khafif A, Lev-Ari S, Vexler A, Barnea I, Starr A, Karaush V, Haif S, Ben-Yosef R.

Laryngoscope. 2009 Oct;119(10):2019-26. doi: 10.1002/lary.20582.

PMID:
19655336
11.

Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer.

Andrzejewski T, Deeb D, Gao X, Danyluk A, Arbab AS, Dulchavsky SA, Gautam SC.

Oncol Res. 2008;17(6):257-67.

PMID:
19192720
12.
13.

Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth.

Liang YJ, Hao Q, Wu YZ, Wang QL, Wang JD, Hu YL.

Int J Gynecol Cancer. 2009 Oct;19(7):1248-52. doi: 10.1111/IGC.0b013e3181b33d76.

PMID:
19823063
14.

Curcumin inhibits telomerase activity in human cancer cell lines.

Cui SX, Qu XJ, Xie YY, Zhou L, Nakata M, Makuuchi M, Tang W.

Int J Mol Med. 2006 Aug;18(2):227-31.

PMID:
16820928
15.

Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells.

Khar A, Ali AM, Pardhasaradhi BV, Begum Z, Anjum R.

FEBS Lett. 1999 Feb 19;445(1):165-8.

17.

Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression.

Malik M, Mendoza M, Payson M, Catherino WH.

Fertil Steril. 2009 May;91(5 Suppl):2177-84. doi: 10.1016/j.fertnstert.2008.03.045. Epub 2008 Jun 13.

PMID:
18555241
18.

Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.

Montopoli M, Ragazzi E, Froldi G, Caparrotta L.

Cell Prolif. 2009 Apr;42(2):195-206. doi: 10.1111/j.1365-2184.2009.00585.x. Epub 2009 Feb 18.

PMID:
19236381
20.

Cell growth regulation.

Karunagaran D, Joseph J, Kumar TR.

Adv Exp Med Biol. 2007;595:245-68. Review.

PMID:
17569215
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk